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Abstract
Authors: Hani M. Elwafi, Katie Witkiewitz, Sarah Mallik, Thomas Thornhill IV, Judson Alyn
Brewer

Cigarette smoking is the leading cause of preventable deaths in the world. A majority of
smokers identify tobacco as harmful and express a desire to quit. Currently available treatments
have shown only modest success, and abstinence rates remain low. Mindfulness Training (MT)
shows promise as an effective treatment for smoking cessation, yet the mechanisms remain
unclear. Craving has been shown to be a central component of the addictive process, and a
strong predictor of smoking. MT is theorized to work by dismantling this addictive process by
targeting craving.

The purpose of this report was to examine the effects of MT on the

relationship between cigarette craving and smoking. We hypothesized that MT would work to
weaken the relationship between craving and subsequent smoking, and that this diminution
would be directly related to the amount of home practice that individuals performed.
33 adults received MT as part of a randomized controlled trial for smoking cessation,
each of whom recorded home practice details in daily diaries. Analyses showed that strong
positive correlations between craving and smoking at baseline (r = 0.582) disappeared by the end
of the treatment period (r = 0.126). Multiple regression models revealed home practice as a
significant predictor of cigarette use (formal: R2=0.315, p=0.004; informal: R2=0.437, p<0.001).
Furthermore, regression analyses revealed that the amount of informal home practice as
measured in days/week moderated the relationship between craving and smoking such that
individuals were smoking less regardless of their level of craving.

These findings suggest that

MT decouples the relationship between smoking and craving, and also show a direct link
between theoretical mechanisms of mindfulness and behavior.
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Introduction
In the US, tobacco use accounts for an estimated 443,000 premature deaths, or
one out of every five deaths, every year

1,2.

For every one American who dies from

smoking, another twenty suffer from at least one serious smoking-related disease

2.

These chronic diseases associated with smoking are estimated to cost society $193 billion
in lost productivity and healthcare costs annually 1.
Despite being deluged with data regarding the dangers of smoking, tens of
millions of Americans continue to smoke daily

3,4.

Yet, the majority of these smokers

identify tobacco as harmful and express a desire quit: a 2010 report from the CDC
indicated that approximately 70% of current smokers want to quit 5. In fact, about 50%
of smokers had tried to quit smoking during the past year, yet the prevalence of recent
cessation was only 6.2% 5. Perhaps even more troubling is the fact that some smokers
appear to simply stop trying to quit as they get older; quit attempts were reported by
62.4% of those aged 18 – 24 years old, compared with 43.5% of those older than 65 years
old 5.

Nicotine is addictive
Every year a significant portion of the millions of people who try to quit smoking
fail within the initial few days or weeks of the cessation effort 6. Among those who
attempt quitting without formal treatment, only 3-5% remain abstinent for 6-12 months
7.

Even among those who do receive treatment, over 60% resume smoking within 30

days of quitting, and almost 90% resume within a year of quitting 8. Data from the
National Comorbidity Survey showed that about 30% of people who have ever tried

2
smoking become daily smokers; the comparable statistics for heroin, cocaine, and
alcohol were 23%, 17%, and 15%, respectively 9.
Clearly cigarettes and other forms of tobacco products are addictive, and of the
over 4000 chemicals found in cigarettes there is little debate in the scientific community
that nicotine is the primary addictive compound found therein 2. A number of factors
contribute to nicotine’s ability to cause such strong addiction. These include: neuroadaptations that occur with chronic intake of nicotine, known as tolerance; the
withdrawal symptoms that most experience upon discontinuation of nicotine intake;
and, the effects of nicotine that reinforce dependence 2.
Tolerance may be understood as reduced responsiveness to a given
concentration of a drug as a consequence of earlier exposure to that drug

10.

There is

ample evidence that, compared to non-smokers, smokers exhibit tolerance to the
subjective effects of nicotine such as “head rush” and nausea

11.

Despite the fact that

tolerance appears to be associated with long-term smokers, debate remains as to
whether it is a consistent marker of nicotine dependence

12.

It is during the onset of

dependence that tolerance to higher doses of nicotine may be of more importance. It is
during this critical time that the development of acute tolerance to the aversive affects of
nicotine must occur to facilitate the likelihood of escalation from a couple of cigarettes
per week to a pack per day or more 13.
In those already dependent on nicotine, the distressing symptoms of withdrawal
are a predictable consequence of abstaining from smoking. This includes, but is not
limited to, restlessness, increased appetite, sleep disturbance, lability, irritability, anger,
anxiety, depression, and difficulty concentrating,

7 14.

However, craving is potentially

the most important feature of nicotine withdrawal 15. It is one of the main reasons cited
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for relapses and lapses, and is often so feared by smokers that they don’t even attempt to
quit despite a desire to. Addressing withdrawal symptoms and the consequent craving
or urge to smoke is a primary treatment strategy to maintain smoking cessation.
Nicotine appears to have a number of behaviorally reinforcing effects that
contribute to both the onset and maintenance of dependence.

A stimulus may be

considered reinforcing if it increases a response or behavior resulting in obtaining that
stimulus. As such, the most commonly used index of reinforcement in smoking and
nicotine addiction research is the number of cigarettes smoked per day, or smoking
frequency, and typically assessed by self-report. The reinforcing effects of nicotine may
be either positive or negative, such as rewarding psychoactive effects of nicotine and/or
the alleviation of aversive states (such as relief from withdrawal symptoms). Other
reinforcing effects of nicotine include the modulation of negative affect (such as
reducing anxiety, sadness, or fatigue) 16, enhancing the ability to maintain attention and
concentration during cognitively demanding tasks

17,

and blunting appetite and

maintaining lower body weight 18.

Addiction Model

Just as important as the primary effects of nicotine on neural functioning are the
associative processes that develop with repeated tobacco use

19.

The acquisition and

maintenance of nicotine dependence is a complex process, one that is developed by
associative learning mechanisms and perpetuated by both positive and negative
reinforcement 20 21 22. Associative memories are often formed between smoking and both
positive and negative affective states, such as after a good meal or after an argument
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with a friend, respectively (Figure 1). If smoking leads to maintenance of the positive
affect, or decreases the negative affect, an associative memory is formed between the
two. Brewer 2010

23 24 25 26.

Going forward, cues that trigger these affective states may

then become associated with smoking, and subsequently induce craving for a cigarette 27
21.

Over time and with repetitive smoking, responding to these cues may become an

automated process which leads to cue-induced behaviors that lay outside of conscious
control 27 28 29. Craving then becomes the central hub of this associative learning loop, as
cues lead to craving, craving leads to smoking, and smoking reinforces the salience of
future external cues and affective states.

Figure 1. Associative learning “addictive loop” for nicotine dependence.
Smoking becomes associated with positive (green) and negative (red) affect through positive and
negative reinforcement. Cues that trigger these states (gray arrows) lead to cue-induced craving,
furthering this process, which through repetition becomes automated over time. Strategies that
teach avoidance of cues or substitute behaviors do not directly dismantle the core addictive loop

5
(black arrows), leaving individuals vulnerable to relapse to smoking. Copyright 2011 Judson
Brewer. Reprinted with permission of author.

Craving
Robinson and Berridge eloquently expressed a basic view held by many
addiction scientists 30:
"To understand addiction, therefore, we need to understand the
process by which drug-taking behavior evolves into compulsive drugtaking behavior. Presumably, this transformation in behavior occurs
because addicts develop an obsessive craving for drugs, a craving that is
so irresistible that it almost inevitably leads to drug seeking and drug
taking" (p. 247).

Craving is unpleasant, and smoking is often motivated by a desire to reduce it.
Individuals who smoke tend to avoid places where they know they cannot smoke, and if
this is not possible they will often become anxious and eager to go to where they can
smoke. Daily schedules are often planned with smoke breaks in mind. Smokers who,
for whatever reason, do not have cigarettes can become so desperate that they will
approach a complete stranger to ask for a cigarette. The longer that craving remains
unsatisfied, the more intense it may become 31.
Craving and subsequent smoking behavior have long been closely associated
amongst daily smokers

20,32-35.

Adults who report higher levels of craving also exhibit

higher levels of daily cigarette consumption
demonstrated in adolescent smokers 37 38.

36,

a relationship that has also been
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West and Schneider define craving as “feelings of need for a cigarette” 15. Some
addiction scientists separate craving by drawing a distinction between desire and intent.
This distinction is noted because, although they are strongly coupled in active smokers
(who, as mentioned, will actively work to overcome obstacles to smoking), the two may
become uncoupled from one another in those who are trying to quit or are in situations
where smoking is not possible 32,39.
The intensity of craving experienced by a smoker, or any addict for that matter,
is influenced by two independent, fluctuating factors: (a) the duration of abstinence
since last use, and (b) the presence of external cues and affective states that have already
attained incentive-motivation significance due to prior associative learning (Figure 1)
40.

33

In smokers, abstinence-induced (i.e. background) craving increases in intensity to a

peak one to two days after quitting and then declines over a number of days or weeks
with continued abstinence 40. On the other hand, cue- or affect-induced craving can arise
within moments upon exposure to cues or triggers

41,

and may even continue to arise

years after quitting 32,42.
Craving is potentially the most important feature of cigarette withdrawal, in that
it is often the most difficult obstacle to overcome for smokers attempting to quit

15 34.

Intense and unremitting craving often precedes the initial lapse following a cessation
attempt, and it is estimated that about 90% of smokers who lapse will progress to have
another lapse often within the same day 43. In fact, a number of studies have shown that
increases in the intensity of craving can accurately predict lapse and relapse risk

33,34,44.

For example, in a study of treatment-seeking smokers, for each standard deviation
increase in craving scores on the target quit date, the risk of lapsing rose by 43% on that
day, and 65% on the following day 45. In a study of women smokers who provided daily
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reports of craving during a 30 day period prior to relapse, craving scores increased by
1.4 standard deviations 4-5 days before, and peaked on the day of relapse 46.

Limitations of currently available treatments

The sheer number of cues that smokers can associate with positive and negative
affective states, in addition to neutral states, greatly complicates quit attempts by
presenting

a

veritable

minefield

of

opportunities

for

relapse.

Current

pharmacotherapies such as nicotine patch, bupropion, or varenicline, have been unable
to prevent cue-induced craving, focused instead on the reduction of background craving
and other symptoms of nicotine withdrawal

47

48

49

50.

Only nicotine gum has

demonstrated efficacy in providing momentary relief from cue-induced craving

51.

However, this is a substitution strategy that does not effectively target affective states
that can themselves induce craving, leaving the aforementioned addictive loop intact.
In addition, most of the current behavioral treatments for smoking cessation also
leave the addiction loop intact (Figure 2). This may be because they focus on teaching
individuals to avoid cues and to divert their attention away from cravings, to substitute
other activities for smoking, or to promote positive affective states by practicing
relaxation or exercising

52 53.

These treatments have shown only modest success, as

abstinence rates in the US have remained under 30% for the past 30 years

52.

This is

perhaps partly due to the ubiquity of cues; avoiding them often takes a lot of cognitive
effort, which may be unavailable during strong affective or ego-depleted states 54 50, and

8
substitutions are not always available or effective. As a result, although it may become
dormant, the addictive loop remains intact and prone to reactivation (Figure 2).

Figure 2. Limitation of current treatment paradigms in dismantling the addictive loop: avoidance
of cues dampens input into the addictive loop (black arrows). While substitute behaviors (blue
arrows) circumvent the targeted addictive behavior (e.g. smoking). However, neither of these
strategies dismantles the addictive loop at its core. Copyright 2011 Judson Brewer. Reprinted
with permission of author.

The evidence for the central role of craving in addiction, coupled with the
shortcomings of current treatments, highlights the need for new approaches

55

31.

The

efficacy of any new approach will hinge on its ability to directly target and dismantle the
core links of the addictive loop.

Recent evidence suggests that treatments such as

Mindfulness Training may do exactly that 56 22 31.

9

Mindfulness Training, Treatment of Addictions

Mindfulness may be described as an awareness of moment-by-moment
experience arising from attention that is characterized by curiosity toward and
acceptance of these present-moment experiences

57 58.

Mindfulness Training (MT) is

derived from Buddhist practices, and adapted for use in Western cultures under a
number of different forms: Mindfulness-based Stress Reduction, Mindfulness-based
Cognitive Therapy, and Mindfulness-based Relapse Prevention
training has been explored as a treatment for pain

59 63,

59 60 61,62.

Mindfulness

anxiety disorders

64 65 66,

and

depression 61 among others.
More recently, Mindfulness Training has been evaluated as a treatment for
addictions

67 62 68

and specifically smoking

56,69 22.

treating addictions remains preliminary, however.

Evidence for the efficacy of MT in
In a recent review of trials that

included mindfulness-based interventions Zgierska et al found that, despite a range of
promising results, very few of the already limited number of clinical trials conducted
prior to 2009 were randomized

70.

Since 2009, several randomized clinical trials have

shown promising results. Brewer and colleagues conducted a pilot study of cocaine and
alcohol dependence and found that after eight weeks of treatment MT had equivalent
efficacy to Cognitive-Based Therapy, the current ‘gold-standard’ treatment for
addictions

68.

In addition, they found that after treatment the subjects who received MT

showed adaptive physiologic and autonomic changes during a laboratory-based stress
challenge that were not observed in the CBT group. In another randomized pilot trial
Bowen and colleagues found that, compared to those receiving treatment as usual,
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subjects who received Mindfulness-Based Relapse Prevention showed significantly
lower rates of substance use up to four months post-intervention 62.
Mindfulness Training has also provided reason for optimism regarding its
efficacy as a treatment for smoking cessation. After an uncontrolled trial Davis and
colleagues reported that 10 of 18 participants who had received MT were abstinent six
weeks after quitting

69.

In another trial Bowen et al found that after providing brief

mindfulness-based instructions (to accept thoughts non-judgmentally, and to pay
attention to urges and accompanying sensations without trying to change or get rid of
them) to college students, they smoked significantly fewer cigarettes seven days postintervention compared to those students who did not receive the instructions

56.

Interestingly, this result was despite the fact that the two groups did not differ
significantly on measures of urges.
More recently Brewer and colleagues conducted a randomized clinical trial in
which participants were randomized to receive either MT or Freedom From Smoking (a
cognitive behavioral therapy based treatment endorsed by the American Lung
Association) as stand-alone treatments for smoking cessation

22.

Compared to

participants who received FFS, those who received MT showed a greater rate of
reduction in cigarette use during treatment and maintained these gains during followup (F = 11.11, p = .001). They also showed a trend towards greater point prevalence
abstinence rate at the end of treatment (36% vs 15%, p = .063), which was significant at
the 17-week follow-up (31% vs 6%, p = .012) 22.
These promising results indicate that Mindfulness Training may be more
effective than current gold-standard behavioral treatments for smoking cessations.

11
However, the psychological mechanisms behind the efficacy of MT remain unknown.
How does MT help cigarette smokers to quit?

Mindfulness Training May Directly Target the Addictive Loop

In teaching the simple concepts of paying attention to and accepting momentary
experience, MT broadly targets different links of the addictive loop, and craving in
particular

71.

By learning to pay attention individuals may be able to ‘de-automate’

habits linked to minimally conscious affective states and sensations 63 72 31. By observing
and non-judgmentally accepting uncomfortable mind- and body-states rather than
reacting to them, MT may help individuals to replace stress-induced habitual reactions
with more adaptive responses 21,31.
By helping people change their relationship to negative affect and physically
unpleasant states (e.g. craving) and thoughts, MT may bolster their ability to ‘ride out’
cravings and subsequently quit smoking or other addictions

31,56,72.

Smokers may learn

to bring mindful awareness to the sensations and thoughts that accompany a craving,
and just observe rather than immediately react to it. This awareness can lead to two
important insights. First, by stepping back and exploring what cravings actually feel
like in their body, an individual may learn that they are physical sensations and not
something they have to get rid of immediately.

Second, each time she rides-out a

craving an individual may learn that they are not permanent and will subside even if
unsatisfied.

Cravings may continue to arise, but by learning to observe and not
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immediately react to them, an individual can begin to disrupt the associative learning
process and dismantle the addictive loop (Figure 3) 31.
Rather than focusing on the removal of stimuli that might propagate the
addictive loop, as with current behavioral treatments, Mindfulness training over time
may lead to the dismantling of the associative learning process of smoking.
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Figure 3: Mindfulness Training targets specific links in the addictive loop, and may help to
dismantle it over time. Copyright 2011 Judson Brewer. Reprinted with permission of author.

The mechanistic underpinnings of MT remain unclear. In order to better
understand whether decoupling the associative connection between craving and
smoking is indeed how MT may help smokers to quit, in the current study we examined
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this relationship between craving and smoking behavior, as well as other factors that
might influence this relationship.

If craving is central to the addictive loop and

strengthens the associative learning process that drives it, while MT theoretically
dismantles this loop, one might wonder whether MT lessens the strength of the
relationship between craving and subsequent smoking behavior. In this report, we
evaluated the relationship between cigarette craving and cigarette use before and after
individuals received MT for smoking cessation. The primary objective was to determine
how the relationship between craving and smoking changed with treatment, and if/how
it was affected by MT, as measured by the amount of formal and informal home practice
that was performed. The secondary objective was to determine if home practice
moderated this relationship. In accord with its theorized mechanism of action, we
hypothesized that individuals would demonstrate a strong correlation between craving
and smoking before treatment, and that this would diminish with MT. We also
hypothesized that the amount of home practice that individuals performed would be
directly related to the diminution of the craving/smoking relationship: the more
individuals practiced, the more craving and smoking would be dissociated.

14

Methods

(Note: this author was not directly involved in recruiting subjects, randomization,
treatment delivery, or follow-up assessments. These were conducted by Brewer and
colleagues as part of the original study

22.

This author was responsible for the

subsequent statistical analyses not presented in the original paper.)

Study Design and Objective

This analysis examined data originally collected by Brewer and colleagues
during a clinical trial evaluating the efficacy of Mindfulness Training for smoking
cessation

22.

The study was a randomized, controlled trial with a 4-week treatment

period, and post-treatment follow-up interviews at 6, 12, and 17 weeks after treatment
initiation.

Their protocol was approved by the Yale University and Veteran’s

Administration institutional review boards.

Study Population:

Eligible subjects were 18 – 60 years of age, smoked >10 cigarettes/day, had fewer
than 3 months of abstinence in the past year, and reported an interest in quitting
smoking. Participants were excluded if they currently used psychoactive medications,
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had a serious or unstable medical condition in the past 6 months, or met DSM-IV criteria
for other substance dependence in the past year.
Of the 103 eligible individuals, 88 were randomly assigned to receive either
Mindfulness Training (MT) or the American Lung Association’s Freedom from Smoking
(FFS) treatment. Participants were urn randomized to either treatment group based on
age, sex, race, and cigarettes smoked per day.

Interventions:

Both MT and FFS treatments were delivered in a group format twice weekly over
4 weeks, for a total of 8 sessions. Sessions were manualized and delivered by instructors
experienced in MT or certified in FFS, respectively. Both MT and FFS had a quit date at
the end of week 2 (session four), were matched for length (1.5 h/session) and delivered
on the same days of the week (Monday and Thursday). In addition, home practice
materials were matched in a number of ways, including the length (!30 min total) and
number of tracks (five) on respective CDs.
FFS served as the ‘standard treatment’ control condition namely because it is a
validated and widely disseminated ‘gold-standard’ treatment for smoking cessation 53 73.
Furthermore, it is manualized, and standards for training and certification of therapists
are established

74.

FFS includes components that are well-matched with MT, but does

not include the hypothesized mechanism of MT as it focuses on avoidance rather than
acceptance of triggers, and substitution strategies instead of awareness of cravings when
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they arise 22. Briefly, the program covered behavior modification, stress reduction, and
relapse prevention, and was divided into three stages: preparation, action, and
maintenance. In the preparation stage (sessions 1–3), participants examined smoking
patterns through self-monitoring, identified triggers, and developed a personalized quit
plan. On quit day (session 4), participants affirmed their decision to quit and identified
specific coping strategies. During the maintenance stage, participants identified ways to
remain smoke-free and maintain a healthy lifestyle (e.g., weight management, exercise,
and relapse prevention), and continued to discuss the importance of social support and
relaxation strategies. Home practice was suggested after each session typically as a
combination of formal (e.g., practicing guided relaxation techniques) and informal (e.g.,
“packtracks”) techniques. Each participant received a practice CD of cessation
techniques.
Mindfulness Training was adapted for smoking cessation from a previous MT
manual for drug relapse prevention 62,68. The main themes of awareness of the moment,
and acceptance of cravings and affect, were introduced and reinforced throughout the
training 59. The first session introduced participants to the concept of how smoking can
become a habituated behavior triggered by an environmental, physical, or mental
stimulus through associative learning. It also explored how cravings feel in the body and
how MT can help individuals become more aware of these processes. Session two
examined how thoughts, emotions and body sensations become triggers for craving and
smoking, and introduced a technique to ‘mindfully’ work with cravings (Recognize,
Accept, Investigate and Note what cravings feel like as they arise, acronym: RAIN).
Session three introduced how difficult emotions perpetuate smoking as well as a
standard meditation technique called loving-kindness as a way to work with them

75.
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Loving-kindness is practiced through directed well-wishing, typically by repetition of
phrases such as ‘may X be happy’. Session four (quit date) taught participants how
cravings thwart long-term goals, and reinforced mindfulness techniques as a way to
help individuals disengage from habitual responding and realign with their goals.
Session five introduced participants to mindfulness practice in everyday life, including
“awareness of breath” meditation and mindful. Session six explored the automaticity of
thought, and how thoughts can lead to habitual behaviors. Session seven reinforced the
concept of acceptance and its role in changing habits. It also explored how both mental
and physical actions can “plant seeds” for future actions and habits. Session eight
summarized the course tools and explored ways of maintaining these in the future 22.
Home practice was suggested after each of the 8 sessions as a combination of
formal and informal MT meditations 22. Formal practices consisted of: 1) the ‘body scan’
which teaches individuals to systematically pay attention to different parts of their
bodies as a way to reduce habitual mind-wandering and strengthen their attentional
capacities, 2) ‘loving-kindness’ meditation, which is practiced by wishing well for others,
usually by repeating a phrase such as ‘may X be happy,’ and 3) ‘awareness of breath’
meditation in which attention is focused on the breath, with the additional intention of
helping individuals become more aware of the present moment and refrain from
habitually engaging in self-related pre-occupations concerning the future or the past.
Informal practices consisted of 1) setting daily aspirations, 2) performing daily activities
mindfully, and 3) techniques designed to mindfully work with cravings (RAIN:
Recognize, Accept, Investigate, and Note) and difficult emotions (SOBER: Stop, Observe,
Breathe, Expand awareness, Respond with full awareness). During treatment, subjects
were instructed to record the amount of formal (number of minutes) and informal
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(number of times) mindfulness practice each day using structured daily diaries. Each
participant received a meditation practice CD.

Post-Treatment Follow-Up Assessment

Participants in both groups were requested to return for follow-up interviews at
6, 12, and 17 weeks post-treatment initiation.

Each of these follow-up interviews

assessed smoking status, craving levels, and information regarding amount and type of
home practice. Participants were instructed to provide general summaries of their home
practice since the end of treatment or previous follow-up visit. This home practice data
was not used in the current analysis due to inconsistencies in the home practice journals.

Study Data Points

Craving levels and smoking status were assessed at baseline, at the end of
treatment, and at follow-up interviews at 6, 12, and 17 weeks post-treatment initiation.
Home practice was recorded daily during the 4 weeks of treatment. A research assistant
who was not involved in treatment delivery checked diary entries twice weekly to
ensure adherence. Data were entered into an electronic database using Teleforms, and
verified by hand.

Smoking Status
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Subjects were instructed to report the number of cigarettes they smoked each day
as part of their structured daily diaries. These were checked twice weekly at in-person
visits by a research assistant who was not involved in treatment delivery. Subjects who
reported continued smoking were assessed by the timeline follow back method (TLFB) 76
77.

Each verification check included exhaled carbon monoxide measurements. Reported

abstinence was verified by an exhaled carbon monoxide measurement of ! 10 parts per
million as previously described 22.

Craving
Subjective craving was assessed using the Questionnaire of Smoking Urges –
Brief (QSU-B)

78 79.

The QSU-B is a 10-item questionnaire that asks subjects to rate, on a

seven-point scale, how strongly they disagree or agree with each question (e.g. “I have
an urge for a cigarette now”). Factor analyses by Cox et al., and confirmed by Toll et al.,
found that this self-reported measure of craving results not only in a total score but also
reflects a two-factor structure. Factor 1 items represent a strong desire and intention to
smoke, while Factor 2 items reflect an anticipation of relief from negative affect with an
urgent desire to smoke 79 80.

Statistical Analysis

Longitudinal data were analyzed using intent-to-treat models on the full sample
of randomized subjects.

Demographics and baseline clinical characteristics were

examined using ANOVA and !2 analysis, using SPSS 19. All tests of significance are
reported as two-tailed, and error is reported as ± standard deviation. Incomplete data
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were handled using the last observation carried forward technique (LOCF), in which
missing values are replaced with the last complete observation for that case. LOCF is an
approach specific to longitudinal designs and is used regularly in clinical trials

81,82 83.

Multiple imputation and case-wise deletion were also used as an alternate, given the
caveats of LOCF 84. As they yielded nearly identical results, only the LOCF analyses are
included in this report.
Pearson Product Moment correlations were used to determine the relationship
between smoking behavior (as measured by average daily cigarette use over the prior
week) and craving levels (as measured by QSU scores). Correlations were calculated at
baseline, at the end of the 4-week treatment period, and at follow-up (6, 12, 17-weeks
from treatment initiation).
Multiple regression analyses was used to assess the degree to which the
independent variable of craving level (i.e. QSU score) predicted smoking behavior (i.e.
average daily cigarette use) with measures of the amount of home practice also included
as independent variables. The equation can be written conceptually as “AvgCigUse "
(W1) Craving + (W2) Home Practice,” where W1 and W2 represent weighting factors
measuring relative importance in the equation. This can be rewritten mathematically as
“Y = A + B1X1 + B2X2.” In terms of output we report r2 values as a measure of the
strength of the association, i.e. a reflection of the percentage of the variation seen in
cigarette use that can be explained by the independent variables.

Effect size was

calculated utilizing Cohen’s f2 measure:
f2 = r2 / (1 – r2)
where r2 is the squared multiple correlation. By convention, f2 effect sizes of 0.02, 0.15,
and 0.35 are termed small, medium, or large 85.
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Moderated regression analysis was performed post-hoc to assess the possibility
that the amount of home practice done by a MT participant might have moderated the
relationship between craving and smoking frequency after 4 weeks of MT treatment. As
described by Baron and Kenny as well as others, a moderator is a variable that alters the
strength or direction of the relationship between a predictor and an outcome variable
87 88.

86

In other words, the impact that an independent variable has on a dependent

outcome variable varies according to the level or value of the moderator 89. In this case,
the hypothesis was that the impact craving had on subsequent smoking behavior was
altered by the amount of home practice that subjects reported.

Figure 4: Diagram of Moderator Effect

Multiple regression techniques may be utilized to examine the effect a
moderator variable has on the predictor of an outcome variable. The moderated
regression equation includes the independent predictor variable, the moderator variable,
and an interaction term that is the represented by the product of the predictor and
moderator

86,90 89.

When two predictors in regression analysis interact with one another,

the regression of the dependent variable on one of those predictors depends, or is
conditional, on the value of the other predictor. The moderated regression equation
takes the form:
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Y = A + B1X1 + B2X2 + B3(X1*X2)

In this equation, the regression coefficients for X1 and X2 reflect conditional
relationships. For example, B1 is the effect of X1 on Y when X2 = 0.

Y = A + B1X1 + B2X2 + B3(X1*X2)
= A + B1X1 + B2(0) + B3(X1*0)
= A + B 1X 1

So, we can say that for a subject who reports home practice (X2) = 0 minutes, a 1 unit
increase in craving score (X1) will produce, on average, a B1 increase in number of
cigarettes smoked (Y).

However, if a subject reports home practice = 100 minutes over the treatment period, the
effect of craving on smoking behavior will be:

Y = A + B1X1 + B2X2 + B3(X1*X2)
= A + B1X1 + B2*(100) + B3(X1*100)
= A + B1X1 + 100B2 + 100B3X1
= A + 100B2 + (B1 + 100B3)X1
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Thus, a one unit increase in craving (X1) will produce a (B1 + 100B3) unit
increase/decrease (depending on the sign of the coefficient) in the number of cigarettes
smoked daily (Y).
Basically, this means that if one asks the question, “What is the effect of craving
level on the number of cigarettes smoked in a day?,” the answer may be “It depends on
how much home practice they’ve done,” i.e. what X2 equals. This response would be
correct if the amount of home practice indeed moderates the relationship between
craving and smoking behavior.

To test this hypothesis, moderated regression was

performed in the style described by Aiken and West

90,

with craving level as the

predictor variable, amount of home practice as the moderator variable, and an
interaction term between the predictor and moderator (= craving x practice).

All

independent variables were mean centered to facilitate the interpretation of conditional
effects and reduce multicollinearity between main effects and the interaction terms 90.
Cohen’s f2 was utilized to calculate the effect size, using the equation:
f2 = [ (r2)AI – (r2)A ] / [ 1 – (r2)AI ]
where (r2)AI is the squared multiple correlation resulting from the full regression model
containing the interaction term, and (r2)A is the squared multiple correlation resulting
from the original regression model without the interaction term. Cohen’s f2 gives the
proportion of systematic variance accounted for by the interaction relative to the
unexplained variance in the criterion. Conventions determined by Cohen: f2 = 0.02 is a
small effect, f2 = 0.15 is a medium effect, and f2 = 0.26 is a large effect 91.
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Results

Baseline Demographics and Clinical Characteristics

Of the 88 randomized subjects, 41 were randomized to the Mindfulness
Treatment group, 32 of which initiated treatment. 47 subjects were randomized to the
Freedom from Smoking group, and 38 initiated treatment.

(Following the

randomization one individual was excluded from the FFS group after being
incarcerated, and his data were not analyzed per Veteran’s Administration regulation.)
!2 and ANOVA analyses revealed no significant differences in baseline demographic
characteristics between the individuals who started treatment and those who did not.
Overall, participants were 46 years old, 55% identified themselves as white, and
63% were men. On average they smoked 20 cigarettes/day, started smoking regularly at
the age of 16, and had 5.2 previous quit attempts. (See Table 1)
Individuals in MT who started treatment (n=32) attended 6.7 ± 1.7 of eight
sessions. The 6, 12, and 17-week follow-up completion rates were 27 (82% of treatmentexposed individuals), 33 (100%), and 29 (88%), respectively. FFS subjects who initiated
treatment (n=38) attended 6.2 ± 2.2 of eight sessions and had 6, 12, and 17-week followup completion rates of 32 (84% of treatment-exposed individuals), 29 (76%), and 33
(87%), respectively.

No serious adverse events were reported in either group.
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Table 1. Baseline Demographic and Clinical Characteristics of Participants
Total,
N=87

MT,
N=41

FFS,
N=46

N (%)

N (%)

N (%)

Variable

Sex
Male

54 (62.1)

27 (65.9)

27 (58.7)

Female

33 (37.9)

14 (34.1)

19 (41.3)

Race
White

43 (49.4)

24 (58.5)

19 (41.3)

Black

34 (39.1)

15 (36.6)

19 (41.3)

Hispanic

9 (10.3)

2 (4.9)

7 (15.2)

Other

1 (1.1)

0 (0.0)

1 (2.2)

Education level
College grad or more

25 (28.7)

12 (29.3)

13 (28.3)

Partial college

25 (28.7)

10 (24.4)

15 (32.6)

High School

31 (35.6)

17 (41.5)

14 (30.4)

Less than high school

6 (6.9)

2 (4.9)

4 (8.7)

Marital Status
Never married

45 (51.7)

20 (48.8)

25 (54.3)

Married/Cohabitating

15 (17.2)

8 (19.5)

7 (15.2)

Separated/Divorced

25 (28.7)

12 (29.3)

13 (28.3)

Widowed

2 (2.3)

1 (2.4)

1 (2.2)

Employment Status

F or Χ2

df

p

.472

1

.492

4.557

3

.207

1.715

3

.634

.376

3

.945

.899

2

.638

Full time

28 (32.2)

15 (36.6)

13 (28.3)

Part time

13 (14.9)

5 (12.2)

8 (17.4)

Unemployed

46 (52.9)

21 (51.2)

25 (54.3)

Continuous Variables

mean (+SD)

mean (+SD)

mean (+SD)

Age

45.9 + 10.2

46.5 + 8.7

45.3 + 11.4

.339

1

.562

Age Started smoking
3x/wk

16.1 + 4.4

16.7 + 4.8

15.6 + 4.0

1.402

1, 85

.240
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# of cigarettes/day

20.0 + 9.5

21.2 + 10.6

# of smokers in house

1.6 + 8.2

.41 + .74

# prior quit attempts

5.2 + 7.2

Longest abstinence, life
(months)
Longest abstinence,
past year (months)

19.0 + 8.3

1.219

1,85

.273

2.7 + 11.2

1.700

1, 85

.196

6.0 + 9.1

4.4 + 4.8

1.037

1, 85

.311

11.4 + 26.8

14.3 + 34.3

8.9 + 17.6

.880

1, 85

.351

.11 + .42

.07 + .35

.15 + .47

.782

1, 85

.379

Effects of Mindfulness Training on Smoking

Brewer et al reported that compared to those randomized to the FFS
intervention, individuals who received MT showed a greater rate of reduction in
cigarette use during treatment and maintained these gains during follow-up (F = 11.11,
p = .001). They also exhibited a trend toward greater point prevalence abstinence rate at
the end of treatment (36% vs. 15%, p = .063), which was significant at the 17-week
follow-up (31% vs. 6%, p = .012) 22.

Correlations between Craving and Cigarette Use

The relationship between craving and smoking behavior at baseline, the end of
treatment, and during follow-up among those subjects who received mindfulness
training was examined utilizing Pearson Product Moment correlations. Scatter plots
were inspected for wayward points, of which there were none. At the start of the 4week treatment period, a strong positive correlation (r = 0.582, p < 0.001) was revealed
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between average daily cigarette use and self-reported craving for cigarettes, as measured
by the Questionnaire on Smoking Urges (See Table 2). In other words, those who
smoked more cigarettes tended to also report higher levels of craving. At the end of the
4-week treatment period, this correlation was reduced to the point of statistical nonsignificance (r = 0.126, p = 0.491). A test of equality of these correlation coefficients
suggested that this was a non-random event (z = 2.05, p = 0.04).
A positive correlation reappeared again at follow-up two weeks after the end of
treatment (r = 0.47, p < 0.02), and grew stronger both three (r = 0.79, p < 0.001) and four
months after treatment initiation (r = 0.77, p < 0.001) as shown in Table 2. This was
likely due to an increased spread in the data (e.g. people who were abstinent at the
follow up time points reported lower levels of cravings and fewer cigarettes smoked,
while those that continued to smoke, reported higher levels of craving and smoking)
(Figure 2).

Interestingly, craving scores at the end of treatment were the same for

individuals who quit smoking and those who did not (Figure 5).

Table 2: Correlations between craving and cigarette use, in relation to home practice with
Mindfulness Training
Variables

Craving
X
Cigarette
Use, Daily
Average

Baseline
(Week 0)

End of
Treatment
(Week 4)

6-Week
Follow-Up

3-Month FollowUp

4-Month
Follow-Up

r = 0.582
p < 0.001
N = 32

r = 0.126
p = 0.491
N=32

r = 0.474
p = 0.020
N = 25

r = 0.788
p < 0.00001
N=28

r = 0.768
p < 0.00001
N=29

Craving was measured by the Questionnaire on Smoking Urges (QSU).
Formal home practice included body scan, loving-kindness, and awareness of breath meditations.
Informal home practice included setting daily aspirations, mindfulness of daily activities, and
RAIN (Recognize, Accept, Investigate, Note) / SOBER (Stop, Observe, Breathe, Expand,
Respond).
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Figure 5: Craving Scores Reported During Treatment and at Follow-Up.

“Abstainers” refers to those subjects who were abstinent from smoking at the 4-month follow-up.
“Non-Abstainers” refers to those subjects who were not abstinent at the 4-month follow-up.
Craving was measured by the Questionnaire on Smoking Urges (QSU).

Pearson Product Moment correlations were also utilized to compare craving
scores and daily cigarette use in the FFS control group. For those subjects treated in the
FFS group, a significant positive correlation can be seen between craving and daily
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cigarette use at baseline (r = 0.361, p = .031), but not at any other time point. It should be
noted that an outlying data point was removed from the baseline data after inspection of
the scatter plot. Prior to the removal of the outlier, the correlation was weakly positive
and non-significant (r = 0.248, p = .139). The removal of the outlier was decided based
upon the fact that it was 2.081 SD deviations away from the mean, as determined by
standardized residuals following a linear regression analysis.

Craving and Mindfulness Home Practice as Predictors of Cigarette Use

As we had previously found that increased home practice was correlated with
decreased cigarette use for both formal (r = -0.44, p < 0.02) and informal practice (r = 0.48, p < 0.01) 22, we next examined the relationship between craving and average daily
cigarette use using linear regression. (Of note, although both groups (MT and FFS)
reported home practices as part of their assigned treatment, only individuals receiving
mindfulness training demonstrated significant correlations between home practice and
smoking outcomes.)
Multiple regression analyses were performed to explore the relative contribution
of craving and home practices in predicting average daily cigarette use. As seen in Table
3, at baseline prior to treatment initiation a regression model with craving as an
independent variable was shown to predict 33.9% of the variance in the average number
of cigarettes smoked daily (B= 3.45 ± 0.88, R2=0.339, p < 0.001, df = 1, 31, f2 = 0.51).
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Following the 4-week treatment period, craving only explained 1.6% of the variance in
smoking (B= 0.41 ± 0.59, R2=0.016, p = 0.491, df = 1, 31, f2 = 0.016).
When home practice was added to craving as a second independent variable in
the regression equation, the model fit improved significantly.

As seen in Table 3, for

example, a model that included both craving and number of days of informal practice
per week predicted 31.5% of the variance in average daily number of cigarettes smoked
(" = -1.35 ± 0.29 ,R2= 0.437, p < 0.0001, df = 2, 31, f2 = 0.78). Thus, for every day of the
week that individuals practiced, they smoked 1.35 fewer cigarettes. We observed the
same relationship between home practice and craving when number of minutes of
formal practice, days per week of formal practice, and number of times of informal
practice were examined (Table 3). Here, individuals smoked .009 fewer cigarettes for
each minute of formal practice, 1.33 fewer cigarettes for each additional day per week of
formal practice, and .03 fewer cigarettes for each time they performed an informal
practice. Effect sizes for these models ranged from .3 (medium to large) to .78 (large)
(Table 3).

31
Table 3: Multivariable Regression Analyses, Average Daily Cigarette Use as
Dependent Variable
Time
Point
Baseline
(Week #0)

Predictor
Variable

r

r2

Model

0.582

0.339

a

b

5.18
Craving
Treatment
End
(Week #4)

Model

3.45
0.126

0.41

.016

2, 31

0.46

2, 31

0.30

2, 31

0.78

2, 31

0.44

+0.88

.58

0.000

+1.56

na

0.051

+0.59

.13

0.491

0.000

0.47

+0.50

.14

0.358

-1.33

+0.38

-.55

0.001

+1.80

na

0.001

0.33

+0.53

.10

0.533

-0.009

+0.003

-.47

0.008

0.437

0.000
+2.47

na

0.001

0.46

+0.45

.14

0.321

-1.35

+0.29

-.65

0.000

0.307

0.004
6.00

Craving
+
Informal
(times)

1, 31

0.173

0.022

Craving
+
Informal
(d/wk)
0.554

0.51

na

10.62

Model

1, 31

na

0.232

Craving
+
Formal
(mins)
0.661

0.000

+2.41

6.39

Model

f2

0.004

Craving
+
Formal
(d/wk)
0.482

df

+3.71

0.315
10.30

Model

p

0.491

Craving
0.561

!

0.016
3.18

Model

SE a,
b

+1.56

na

0.000

0.56

+0.50

.17

0.275

-0.03

+0.008

-.54

0.002
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Craving was measured by the Questionnaire on Smoking Urges (QSU).
Formal home practice included body scan, loving-kindness, and awareness of breath meditations.
Informal home practice included setting daily aspirations, mindfulness of daily activities, and
RAIN (Recognize, Accept, Investigate, Note) / SOBER (Stop, Observe, Breathe, Expand,
Respond).

Moderation of the Relationship Between Craving and Smoking by Mindfulness Home Practice

Given the strong association between mindfulness practice and smoking, as well
as the lack of an association between craving and smoking after four weeks of treatment,
we were next interested in whether mindfulness home practice changed the association
between craving and smoking over the course of treatment. To examine this question
we conducted moderated regression analyses with baseline levels of craving and
smoking, craving at four weeks, and the interaction between craving and each form of
mindfulness practice as predictors of cigarettes per day at four weeks following
treatment.

Results from the moderated regression indicated that days of informal

practice significantly moderated the association between craving and smoking at four
weeks following treatment (B= 0.52 ± 0.22, p = 0.03, f2 = 0.18). A bivariate scatter plot for
the association between craving and smoking at 4-weeks following treatment, at levels
of informal practice, split into groups of individuals who practiced informally at least 6
out of 7 days (n = 21) as compared to those who practiced on fewer than 6 days (n = 11)
suggesting that the association between craving and smoking is actually stronger in the
group that practiced more (Figure 6). Yet, the individual data points indicated that 5 of
the individuals who practiced daily and never smoked also reported higher levels of
craving.

Further inspection of this effect indicated that individuals who practiced

informally at least 6 out of 7 days were smoking significantly fewer cigarettes per day (t
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(30) = 3.10, p = 0.004, d = 1.05) than those who engaged in fewer than 6 days of practice,
yet they were not reporting lower levels of craving (t (30) = -0.76, p = 0.45, d = .30). Thus
individuals who engaged in more days of informal practice were experiencing similar
levels of craving and were smoking significantly less than those who engaged in fewer
days of informal practice (Figure 7).

Figure 6: Bivariate scatter plot for the association between craving and smoking at 4-weeks following
treatment, at levels of informal practice, split into groups of individuals who practiced informally at least 6
out of 7 days (n = 21) as compared to those who practiced on fewer than 6 days (n = 11)
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Figure 7: Moderating effect of the number of days per week of informal practice on the association between
craving and smoking.
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Discussion:

The primary aim of this study was to identify potential psychological
mechanisms underlying the clinical effects of MT in reducing smoking.

Given the

theoretical underpinnings of MT, we hypothesized that the relationship between craving
and smoking behavior would diminish after MT. The results of this analysis appear to
support that hypothesis.

Following four weeks of MT, the significant and strong

positive correlation between craving and smoking behavior (r = 0.582, p < .001), seen
among participants initially at baseline, is reduced in strength to the point of statistical
non-significance (r = 0.126, p < 0.126). To the best of our knowledge, this is the first
analysis to show that MT may decouple the positive correlation commonly seen between
craving and smoking.
Multiple regression analyses further supported the hypothesis that after MT the
relationship between craving and smoking behavior is diminished.

At baseline,

regression models reveal craving to significantly predict 33.9% of the variance in how
many cigarettes are smoked per day (B= 3.45 ± 0.88, R2=0.339, p < 0.001, df = 1, 31, f2 =
0.51). Following the 4-week MT treatment period, craving only explained 1.6% of the
variance in smoking (B= 0.41 ± 0.59, R2=0.016, p = 0.491, df = 1, 31, f2 = 0.016). Upon
addition of home practice as a second independent variable, the regression models once
again become significantly predictive of the number of cigarettes smoked per day.
These models all showed large effect sizes (Cohen’s f2).

Furthermore, regression

analyses revealed that the amount of informal home practice as measured in days/week
moderated the relationship between craving and smoking such that individuals were
smoking less regardless of their level of craving.
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These results suggest that the positive relationship between high levels of
craving and frequency of smoking that has been consistently observed, i.e. the ability of
craving level to predict smoking behavior can be specifically modified by targeted
treatment, leading to a vastly different outcome

15 39 92 93 38 35.

As previously stated, MT

may help participants to more effectively ‘ride out’ their cravings. Cravings could still
arise, but the practice of sitting with urges, pausing and not immediately reacting to
them, may disrupt the associative learning process and the automaticity of the action
habitually taken. As hypothesized earlier, if this is indeed true then MT should affect
the traditional observation that smoking and craving are positively correlated. Or, in
other words, the success that a recipient of Mindfulness Training might have in cutting
down or quitting smoking cigarettes would not necessarily due to, nor a consequence of,
diminished craving, but instead due to a different relationship to craving.

Taken

together, these results suggest that mindfulness training may indeed help individuals
develop a tolerance to craving itself, thus over time acting to dismantle the addictive
loop.

Importantly, the findings from this study also support the postulate that

treatments that specifically target the relationship between craving and subsequent
smoking can fundamentally change this relationship, leading to healthier behavior, and
leads to benefits for the individual and society.
Through specifically targeting craving, our data suggest that MT may confer
several advantages over standard cognitive therapy for addictions (e.g. FFS). First,
instead of teaching a number of different techniques aimed at different components of
the addictive loop (e.g. both avoidance of triggers and substitution of a more healthy
behavior when craving arises, Figure 2), it teaches individuals to simply observe and ‘be
with’ cravings, no matter what triggers them (cue or affect). In such, it may help people
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to learn one technique well, rather than dividing cognitive resources to learn several
techniques

22.

This may be more supportive of successful quit attempts, especially in

situations in which individuals are vulnerable to relapse, such as during strong affective
states or when cognitively depleted

54,

as mindfulness meditation has recently been

shown to counteract self-control depletion in a laboratory setting

94.

Comparing these

types of probes between cognitive and mindfulness treatments in clinical populations
may help to delineate the relative potential benefits of each of these treatments for
particular patient populations, leading to improved individualization of treatment.
Strengths of this study include the use of a theory-based, hypothesisdriven design for analysis, and validated measures. A number of limitations of this
study are worth mentioning. First, it was of moderate size, which may have limited our
ability to detect moderation effects of some home practices on the relationship between
craving and smoking. Nonetheless, we still found significant effects of home practice in
our primary analysis, and effects of moderation of informal home practice on the
craving-smoking correlations. Future, larger studies that are sufficiently powered to
detect effects of home practices that had smaller effect sizes are warranted. Second, daily
home practice was only measured during treatment. Additional studies assessing daily
practice after treatment completion will be important to determine the relationship
between continued practice after treatment completion, craving and smoking behavior.
In conclusion, results from this study suggest that one possible
psychological mechanism of how MT exerts its effect on smoking behavior is through
decoupling the relationship between craving and smoking. Larger studies that not only
replicate these findings but test other possible mechanisms of action as well are
warranted.
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